Efforts to Define a Role for Recombinant Erythropoietin in Cancer Management

Publisher： Karger

E-ISSN： 1423-0232|71|3-4|149-150

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.3-4, 2008-06, pp. : 149-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

By  

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 115-115

Karger

Access to resources Recommend Favorite

Patient‐derived organoid models help define personalized management of gastrointestinal cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 2, 2018-01 ,pp. : e48-e60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 46-53

Karger

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 216-221

Karger

Access to resources Recommend Favorite

Erythropoietin in the Treatment of Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 181-182

Karger

Access to resources Recommend Favorite